Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-02-28

Clinical Trial Update: Cellulose Sulfate (CS) Gel and HIV in Nigeria [Phase 3]

View source ↗

Summary

A Phase 3 trial of cellulose sulfate gel for HIV prevention in Nigeria was terminated. The study evaluated HIV infection prevention and other sexually transmitt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cellulose Sulfate Gel (cellulose sulfate gel)

Snippet

Sponsor: FHI 360 | Conditions: HIV Infections, Gonorrhea | Phase 3 | Status: TERMINATED